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ABSTRACT: Three-dimensional (3D) cell culture is regarded as a more physiologically relevant method of growing cells in the
laboratory compared to traditional monolayer cultures. Recently, the application of polystyrene-based scaffolds produced using
polyHIPE technology (porous polymers derived from high internal phase emulsions) for routine 3D cell culture applications has
generated very promising results in terms of improved replication of native cellular function in the laboratory. These materials,
which are now available as commercial scaffolds, are superior to many other 3D cell substrates due to their high porosity,
controllable morphology, and suitable mechanical strength. However, until now there have been no reports describing the
surface-modification of these materials for enhanced cell adhesion and function. This study, therefore, describes the surface
functionalization of these materials with galactose, a carbohydrate known to specifically bind to hepatocytes via the
asialoglycoprotein receptor (ASGPR), to further improve hepatocyte adhesion and function when growing on the scaffold. We
first modify a typical polystyrene-based polyHIPE to produce a cell culture scaffold carrying pendent activated-ester functionality.
This was achieved via the incorporation of pentafluorophenyl acrylate (PFPA) into the initial styrene (STY) emulsion, which
upon polymerization formed a polyHIPE with a porosity of 92% and an average void diameter of 33 μm. Histological analysis
showed that this polyHIPE was a suitable 3D scaffold for hepatocyte cell culture. Galactose-functionalized scaffolds were then
prepared by attaching 2′-aminoethyl-β-D-galactopyranoside to this PFPA functionalized polyHIPE via displacement of the labile
pentafluorophenyl group, to yield scaffolds with approximately ca. 7−9% surface carbohydrate. Experiments with primary rat
hepatocytes showed that cellular albumin synthesis was greatly enhanced during the initial adhesion/settlement period of cells on
the galactose-functionalized material, suggesting that the surface carbohydrates are accessible and selective to cells entering the
scaffold. This porous polymer scaffold could, therefore, have important application as a 3D scaffold that offers enhanced
hepatocyte adhesion and functionality.
■ INTRODUCTION
Substantial evidence exists to support three-dimensional (3D)
cell culture as a more physiologically relevant growth environ-
ment compared to that with conventional monolayer
cultures.1−4 Cells cultured in 3D more closely mimic their native
morphology, unlike monolayer cultures in which cells are often
flattened into a two-dimensional (2D) shape. Cells in the 3D
environment can also experience more interaction with their
Received: August 1, 2013
Revised: October 31, 2013
Published: November 1, 2013
Article
pubs.acs.org/Biomac
© 2013 American Chemical Society 4271 dx.doi.org/10.1021/bm401145x | Biomacromolecules 2013, 14, 4271−4277
Terms of Use CC-BY
neighbors, in turn increasing cellular communication that is
important in regulating normal cell function. Recognizing these
advantages associated with a 3D growth environment, many
researchers now require practical technologies that can enable
routine 3D cell culture in the laboratory.5
Synthetic, nonbiodegradable, porous polymers are attractive
materials as routine 3D scaffolds as they are inert, reproducible,
and can be engineered into a versatile range of morphologies.
Recently, several groups have employed porous polymers
derived from high internal phase emulsions (polyHIPEs) as
scaffolds for 3D cell culture.6−11 In particular, polystyrene-based
polyHIPE scaffolds have shown very promising results with a
range of different cell types due to their controllable morphology,
high porosity and suitable mechanical properties.12−16 These
materials are also now available as commercial 3D scaffolds
(AlvetexScaffold by Reinnervate) and have already been adopted
by a broad range of research groups.17,18
One potential limitation of polystyrene-based polyHIPEs as
3D cell scaffolds is surface chemistry. Cells in vivo are surrounded
by a complex extracellularmatrix that contributes to cell anchorage
and function. They also receive a plethora of biochemical cues
from molecules such as carbohydrates and proteins that serve to
regulate normal cell behavior. Being able to mimic some of these
biological interactions on the surface of synthetic 3D scaffolds is
therefore an attractive prospect.19 However, achieving this for
polystyrene-based polyHIPEs is challenging. Postpolymerization
modifications of polystyrene are possible but often require harsh
reaction conditions due to the inert nature of the polymer.20,21
Similarly, including a new functional comonomer into the pre-
polymerized emulsion can often disrupt emulsion stability and
thus distort polyHIPE morphology. Recently, several groups
have successfully overcome the latter issue by employing func-
tional comonomers that are sufficiently soluble in the styrene
(STY) external emulsion phase. For example, Krajnc et al.
demonstrated that methacrylic acid could be incorporated.22
Heise et al. reported that 4-vinylbenzylphthalimide could be
incorporated for subsequent polypeptide attachment.23,24 Other
groups have also previously included 4-vinylbenzyl chloride.25,26
All of these functional comonomers potentially offer a useful
functional ‘hook’ on the polyHIPE surface as a route to facile
attachment of various (bio)molecules, such as proteins or
carbohydrate residues.
Our work therefore describes the inclusion of an ester
comonomer into a styrene-based emulsion as a facile route to
polyHIPE surface modification with aminoethyl glycosides. We
show that a polystyrene-based polyHIPE containing pentafluor-
ophenyl acrylate (PFPA) can be produced with a suitable
morphology to support 3D cell growth (photopolymerised
polyacrylate polyHIPEs incorporating PFPA have been
described previously27). A straightforward postpolymerization
functionalization of this material was then employed to attach
pendent galactose residues via aminoethyl glycoside coupling
with PFPA, similar to the strategy described by Boyer and Davis
for solution-based glycopolymer synthesis.28−30 The selectivity
and accessibility of the pendent galactose residues was demon-
strated by the culture of primary rat hepatocytes, which contain a
cell-surface asialoglycoprotein receptor (ASGPR31) that can
specifically bind to galactose for enhanced cell adhesion and
function.32,33 Glucose-functionalized polyHIPEs were also
prepared as a selectivity control for galactose during the primary
rat cell adhesion experiments.
■ MATERIALS AND METHODS
Materials. The monomers styrene (STY), divinylbenzene (DVB),
and 2-ethylhexylacrylate (EHA) were obtained from Sigma Aldrich and
used without further purification. Span80 and anhydrous dimethylfor-
mamide (DMF) were also obtained from Sigma Aldrich. The poly-
merization initiator 2,2′-azobisisobutyronitrile (AIBN) was supplied by
Acros Organics and recrystallized from methanol before use.
Pentafluorophenyl acrylate (PFPA),34 2′-aminoethyl-β-D-glucopyrano-
side, and 2′-aminoethyl-β-D-galactopyranoside35 were synthesized as
described in the literature. Characterization data were in accord with
published values.
The hepatocellular carcinoma HepG2 cell line was supplied by the
American Type Culture Collection (ATCC). Rat Sprague−Dawley
pooled cryopreserved primary hepatocytes (Grade P) were obtained
from Biopredic International along with the thawing medium. Culture
medium materials were used according to ATCC and Biopredic
recommendations for HepG2 and primary rat hepatocytes, respectively.
The Albumin ELISA kit was obtained from Universal Biologicals
Cambridge. The AlvetexScaffold polyHIPE and associated plastic clips
and well inserts used to house the polyHIPE membranes during cell-
culture were supplied by Reinnervate.
PolyHIPE Nomenclature. The SDE-polyHIPE corresponds to
the parent unfunctionalised polyHIPE derived from STY, DVB, and
EHA. The xPFPA-SDE-polyHIPEs correspond to the different PFPA-
functionalized SDE-polyHIPEs, where x denotes the % PFPA in the
initial HIPE monomer mixture. The Gal-SDE-polyHIPE refers to the
resulting material after coupling the 26PFPA-SDE-polyHIPE with
2′-aminoethyl-β-D-galactopyranoside. The Glu-SDE-polyHIPE refers to
the resulting material after coupling the 26PFPA-SDE-polyHIPE with
2′-aminoethyl-β-D-glucopyranoside.
PFPA-SDE-polyHIPE Synthesis andMorphological Character-
ization. The preparation of polystyrene-based porous polymers by
emulsion templating has already been well documented.8,14,15 Specific
HIPE formulations for this study are shown in Table S1 in the
Supporting Information. Briefly, an oil phase consisting of the organic
monomers, AIBN initiator, and surfactant Span80 were placed in a
250 mL 3-necked round-bottomed flask and stirred continually at
350 rpm using a PTFE paddle connected to an overhead stirrer. To this
organic phase, deionized water was slowly added at room temperature
via a dropping funnel. Stirring continued for an additional 2 min after the
last water droplet was added, before transferring the high internal phase
emulsion (HIPE) to a 50 mL centrifuge tube. The tube was then placed
in a 60 °C oven for 24 h to polymerize. The resulting polyHIPE
monolith was then Soxhlet washed in acetone for 24 h and left to air-dry
overnight in a fume hood.
The morphology of the polyHIPEs was investigated using a Phillips
XL30 ESEM operating in SEM mode between 10 kV and 25 kV.
Samples were first mounted on carbon fiber pads preadhered to
aluminum stubs and then gold coated using an Edwards Pirani
501 sputter coater before imaging. ImageJ software was used to measure
void diameters on each micrograph. Mercury intrusion porosimetry was
performed using aMicromeritics AutoPore IV using penetrometers with
a stem volume of 1.836 mL and a bulb volume of 5 mL. Analysis was
performed from 0.5 to 1600 psi.
HepG2 Culture and Histological Analysis on the 26PFPA-
SDE-polyHIPE.HepG2 cells were precultured in T75 flasks before use.
The 26PFPA-SDE-polyHIPE monolith was sectioned into 200 μm
membranes using a Leica VT1000S vibrotome and then cut into
circles of 15 mm diameter using a bore-cutter. These discs, along with
AlvetexScaffold discs (commercial SDE-polyHIPE control), were
quickly submerged in ethanol and then washed extensively with PBS
before being housed in plastic inserts in a 12-well plate. Then, 0.4 million
cells were added to each polyHIPE via a 100 μL media suspension, and
cells were cultured for 5 days at 37 °C and 5% CO2 in 4 mL of media.
After this period, cells were fixed in Bouin’s fixative, dehydrated using
ethanol, and embedded into paraffin wax. Tenmicrometer sections were
then used for hematoxylin and eosin staining.
PFPA-SDE-polyHIPE Functionalization with Aminoethyl Gly-
cosides. The 26PFPA-SDE-polyHIPE monolith was sectioned into
200 μmmembranes using a Leica VT1000S vibrotome and then cut into
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circles of 15 mm diameter using a bore-cutter. Six discs were then placed
in a glass vial containing 12 mL of dimethylformamide and 60 mg of
either 2′-aminoethyl-β-D-galactopyranoside or 2′-aminoethyl-β-D-
glucopyranoside. The vials were then placed in a shaker oven at 40 °C
for 48 h with the shaker operating at 150 rpm. Samples were then slowly
rehydrated though a series of Milli-Q water-dimethylformamide
gradients so as not to collapse the polyHIPE structure during deswelling.
The functionalized polyHIPEs were then washed in Milli-Q water and
then left to dry before analysis.
Detection of Surface Carbohydrates. Attenuated Total
Reflection Fourier Transform Infra Red (ATR-FTIR) spectra were
recorded on a Perkin-Elmer 1600 Series FTIR spectrometer fitted with a
Golden Gate ATR element. Solid samples were pressed using a spatula
before being placed on the crystal. Spectra were evaluated with Omnic,
version 7.3. 13C solid state NMR spectra were recorded on a Varian
VNMRS 400 spectrometer at a frequency of 100.56 MHz using direct
excitation with proton decoupling. Spectra were obtained with total
sideband suppression (TOSS). 19F solid state NMR spectra were
recorded on a Varian Unity Inova 300 spectrometer at a frequency of
282.10 MHz, using direct polarization and no decoupling. Spectra were
evaluated with MestReNova, version 8.1.1−11591.
X-ray photoelectron spectroscopy (XPS) was performed at the
National EPSRCXPS User’s Service (NEXUS) at Newcastle University.
A K-Alpha instrument equipped with a monochromated AlKa source
(Thermo Scientific) was used. A pass energy of 40 eV and a step size of
0.1 eV was used for high resolution spectra of the elements of interest.
Spectra were analyzed using Casa XPS licensed at Newcastle University.
Primary Rat Hepatocyte Culture and Albumin Analysis.
Cyropreserved primary rat hepatocytes were brought up from frozen
and diluted into prewarmed thawing medium. Cells were then
resuspended into culture medium to give a final concentration of
0.2 million cells per 1 mL of media. PolyHIPE discs were quickly
submerged in ethanol and then washed extensively with PBS before
being clipped into the wells of a 24-well cell-culture plate. One milliliter
of the cell suspension was added to each polyHIPE, and the cells were
cultured at 37 °C and 5% CO2. Albumin assessments were carried out
using a rat-specific albumin ELISA (Assaypro ERA3201-1) according to
the protocol provided with the kit.
■ RESULTS AND DISCUSSION
PolyHIPEs derived from styrene STY, DVB, and EHA have been
previously reported as suitable scaffolds for routine 3D cell
culture.12,16,36 The main component of these polyHIPEs is STY
(∼60% of monomer mixture), with DVB present as a cross-
linking comonomer to increase the mechanical strength and
EHA present to increase polymer elasticity by reducing the Tg.
This type of polyHIPE, termed SDE-polyHIPE for the purpose
of this study, was therefore chosen as the parent material to be
functionalized via a two-step strategy, as shown in Figure 1.
SDE-polyHIPEs are often fabricated using a nonionic
surfactant with a low HLB, such as Span80, which is insoluble
in the dispersed phase and so inhibits emulsion phase separation.
Electrolytes such as calcium chloride (CaCl2) are also sometimes
used in the fabrication process of these materials to promote
emulsion stabilization by improving surfactant packing at the
interface.37 However, in this study we chose to exclude CaCl2
because the additional organic phase component PFPA was
expected to provide some extra emulsion stabilization and
consequently a reduction in void diameter. SDE-polyHIPEs are
also usually fabricated with potassium persulfate (KPS) as the
free radical initiator, which being water-soluble, favors polymer-
ization of those monomers found in excess at the interface.
However, we chose AIBN as the initiator for this study since the
interfacial activity of PFPA in comparison with that of the other
monomers was unknown.
PFPA Functionalization of SDE-polyHIPE. The first step
toward galactose-functionalized polystyrene-based polyHIPEs
Figure 1. Schematic showing the synthetic strategy for incorporating carbohydrate functionality onto the surface of a polystyrene-based polyHIPE
(SDE-polyHIPE). Step 1 involves the incorporation of PFPA into the material to leave pendent ester functionality (PFPA-SDE-polyHIPE). Step 2 then
involves a coupling reaction between the ester functional groups on the polyHIPE and the aminoethyl glycosides (1) and (2). Reaction (i) conditions:
AIBN, 60 °C, and 24 h. Reaction (ii) conditions: DMF, 40 °C, and 48 h.
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was to include PFPA as a functional comonomer into the parent
HIPE to render pendent ester functionality in the polymerized
monolith. PFPA was chosen as a suitable monomer as it has
hydrophobicity similar to that of STY (log PPFPA = 2.55
38 and log
PSTY = 2.95
39) and thus was not expected to significantly disrupt
HIPE stability. PFPA has also been previously reported to
undergo facile coupling reactions with amines when incorpo-
rated into photopolymerized polyacrylate polyHIPEs,27 as
well as when polymerized as a poly(PFPA) homopolymer.40
Furthermore, PFPA contains 5 flourine atoms that are
conveniently detectable by NMR and X-ray photoelectron
spectroscopy (XPS).
An oil phase was prepared containing the organic monomers
(STY, DVB, EHA, and PFPA), AIBN and Span80. To this,
an aqueous water phase was added and the mixture stirred
vigorously to form HIPE. Increasing PFPA monomer concen-
trations were attempted, namely, 10 wt %, 20 wt %, 26 wt %,
33 wt %, and 43 wt % relative to the total monomer mixture (see
Table S1 in Supporting Information for complete HIPE com-
positions). All formulations formed a stable HIPE with no
apparent signs of phase separation. The HIPE mixtures were
then thermally polymerized at 60 °C for 24 h to form PFPA-
SDE-polyHIPEs.
The morphologies of the polymerized PFPA-SDE-polyHIPEs
are shown in Figure 2. A typical SDE-polyHIPE morphology was
observed for all PFPA-SDE-polyHIPE materials except for the
43PFPA-SDE-polyHIPE (where 43 corresponds to ∼43 wt % of
the initial monomer mixture being attributed to PFPA). The
morphology of this material was found to be collapsed and with
unidentifiable voids. For those materials that resembled typical
polyHIPE morphologies, an overall decrease in void diameter
was observed with increasing PFPA concentration, from approx-
imately 69 μm (control: 0 wt % PFPA) to 28 μm (33 wt %
PFPA). Table S2 in the Supporting Information contains specific
physical characteristics for each polyHIPE. This trend toward
smaller void sizes suggests an increase in emulsion stability with
higher PFPA incorporation, which is likely the result of the
higher organic content helping to form wider and more robust
continuous phase films around the internal phase droplets.
This hypothesis is supported in the case of the 43PFPA-SDE-
polyHIPE, where the strut thickness of the material is visibly
larger than those polyHIPEs with lower PFPA content (Figure 2,
white arrow).
The average interconnect diameter also decreases with
increasing PFPA content, which is to be expected given that
void diameter decreases (again refer to Table S2, Supporting
Information). Figure 3 shows the interconnect diameter
distribution for PFPA-SDE-polyHIPEs. Generally, a wider
distribution in interconnect diameter was observed with higher
levels of PFPA incorporation.
The porosities of all materials remained high (∼90%),
although a general decreasing trend was observed with increasing
PFPA concentration (Table S2, Supporting Information), which
is to be expected with an increasing organic phase content and
therefore a lowered internal phase volume fraction.
Overall, 26PFPA-SDE-polyHIPE appeared to display opti-
mum physical characteristics for the maximum theoretical PFPA
loading. The material has an average void diameter of 33 μm and
an average interconnect diameter of 10 μm, compared to 69 and
15 μm, respectively, in the parent control SDE-polyHIPE. This
difference was deemed acceptable, given that many cells have
diameters in the region of 15 to 25 μm and therefore sufficiently
smaller than the 33 μm voids in 26PFPA-SDE-polyHIPE.
Furthermore, the commercial AlvetexScaffold has an average
void diameter of 42 μm. To check the compatibility of
the 26PFPA-SDE-polyHIPE morphology for 3D cell growth,
we cultured HepG2 cells (a hepatocyte-derived cell line) on the
material. Figure 4 shows a histological cross-section of the cells
after 5 days of growth. Cells anchored onto the PFPA-
functionalized polyHIPE in a manner similar to that with
AlvetexScaffold and formed a tissue-like layer in the top portion
of the membrane. All cells appeared healthy and viable with no
signs of necrosis. The penetration of cells into the material was
slightly less compared to that with AlvetexScaffold. This would
be expected given that AlvetexScaffold has a slightly larger
average void diameter. Nonetheless, cells still managed to enter
the PFPA-functionalized material after only 5 days of culture.
Carbohydrate Functionalization of 26PFPA-SDE-poly-
HIPE. 2′-Aminoethyl-β-D-galactopyranoside (galactose-amine
Figure 2. Scanning electron micrographs showing the morphologies of
the different PFPA-SDE-polyHIPEs. The white arrow indicates thicker
struts in the 43PFPA-SDE-polyHIPE material. Scale bars = 50 μm.
Figure 3. Interconnect diameter distribution for the different PFPA-
SDE-polyHIPEs. The numbers in the legend correspond to the different
PFPA concentrations added to the SDE-HIPE formulations (wt % in
total monomer mixture).
Biomacromolecules Article
dx.doi.org/10.1021/bm401145x | Biomacromolecules 2013, 14, 4271−42774274
(1)) and 2′-aminoethyl-β-D-glucopyranoside (glucose-amine
(2)) were chosen for reaction with the 26PFPA-SDE-polyHIPE.
These aminoethyl glycosides were chosen over galactosamine
and glucosamine in order to lock the carbohydrate in the
beta conformation after coupling with the PFPA ester. With
galactosamine and glucosamine, the amine group is attached to
the 2-carbon leaving the 1-carbon free. This can therefore lead to
ring-opening of the carbohydrate into the open-chair form and
thus the subsequent cyclic rearrangement into alpha, beta, and
furanoside forms that may jeopardize binding with the ASGPR.
PolyHIPE was first sectioned into 200 μmmembranes and cut
into discs of 15 mm in diameter. These discs were then mixed
with a solution of aminoethyl glycoside in DMF for 48 h at 40 °C
under constant agitation. The resulting materials, termed either
Gal-SDE-polyHIPE or Glu-SDE-polyHIPE due to galactose or
glucose coupling, respectively, were then slowly rehydrated and
washed extensively with Milli-Q water before characterization.
Figure 5 shows the ATR-FTIR spectra for 26PFPA-SDE-
polyHIPE along with Gal-SDE-polyHIPE and Glu-SDE-polyHIPE.
All materials contain a peak at 1732 cm−1, which corresponds to
the EHA carbonyl group from the parent SDE-polyHIPE
formulation (EHA ester CO stretching). The presence of
the PFPA in the starting material is confirmed by the peaks at
996 cm−1 (C−F stretching), 1520 cm−1 (Ar CC stretching), and
1786 cm−1 (PFPA ester CO stretching). For the carbohydrate-
functionalized materials, these peaks almost disappear, which is
consistent with the loss of pentafluorophenol during nucleophilic
substitution. The spectra of the carbohydrate-functionalized
materials have additional peaks at 1658 cm−1 (amide CO
stretching) and 3400 cm−1 (O−H stretching).
Figure 6 shows the solid state NMR spectra (13C and 19F) for
26PFPA-SDE-polyHIPE along with Gal-SDE-polyHIPE and
Glu-SDE-polyHIPE. A new carbon peak occurs at ∼70 ppm in
the 13C spectra of the carbohydrate-functionalized materials
(C−OH) that is not present in the starting 26PFPA-SDE-
polyHIPE. Similarly, a complete disappearance of fluorine peaks
is observed in the 19F spectra for both carbohydrate-function-
alized materials, suggesting a near complete conversion to the
amide-carbohydrate.
XPS was used to quantify the amount of PFPA and carbo-
hydrate on the surface of 26PFPA-SDE-polyHIPE, Gal-SDE-
polyHIPE, andGlu-SDE-polyHIPEmaterials. Figure 7 shows the
peak-fitted high resolution C1s spectra for the three materials.
F1s and N1s high resolution spectra can also be found in the
Supporting Information, along with surface atomic concen-
trations from survey spectra (Table S3, Supporting Information).
Peaks were fitted for (a) C−C, CC at a binding energy (BE)
of 285.11 eV, (b) C−OH, C-OC at a BE of 286.00 eV, (c)
C−O−CO at BE’s of 286.81 and 288.93 eV, (d) C−F at BE of
287.12 eV, and (e) OC−N at BE of 288.13 eV. Noticeably
larger peak areas for C−F and C−O−CO are observed for
26PFPA-SDE-polyHIPE compared to the carbohydrate-
functionalized materials. Quantification shows that the
26PFPA-SDE-polyHIPE contains ca. 9% PFPA, whereas Gal-
SDE-polyHIPE and Glu-SDE-polyHIPE contain ca. 0%. This
loss of PFPA compared to the original 26 wt % in the initial
emulsion has also been observed in other polyHIPE systems27
and may be attributed to either partial PFPA solubility in the
aqueous phase, hydrolysis of the pentafluorophenyl ester, or
incomplete PFPA polymerization. Both carbohydrate-function-
alized materials display new peak areas for C−OH/C-OC and
OCN that are absent in 26PFPA-SDE-polyHIPE. Quantifica-
tion shows that the materials contain between ca. 7% and 9%
carbohydrate, suggesting a near complete conversion from ester
to amide under the reaction conditions employed.
Primary Rat Hepatocyte Culture on Galactose-Func-
tionalized SDE-polyHIPEs. Hepatocytes are the main func-
tional cells of the liver and are used extensively as in vitromodels
for drug toxicity screening.41 However, primary hepatocytes
taken directly from a patient or animal are notoriously difficult to
culture, with a rapid loss of differentiated phenotype occurring
almost instantly after removal from the native tissue.
Consequently most functional experiments with primary rat
Figure 4. Haematoxylin and Eosin staining of HepG2 cells cultured on
commercial SDE-polyHIPE (AlvetexScaffold) (A) and 26PFPA-SDE-
polyHIPE (B) after 5 days. Scale bar = 20 μm.
Figure 5. (a) ATR-FTIR spectra of 26PFPA-SDE-polyHIPE (i), Gal-
SDE-polyHIPE (ii), and Glu-SDE-polyHIPE (iii). (b) Expansion of the
range 1400−1900 cm−1 (order of spectra is the same as that in panel a).
Figure 6. 13C (A) and 19F (B) solid state NMR spectra of 26PFPA-SDE-
polyHIPE (i), Gal-SDE-polyHIPE (ii), and Glu-SDE-polyHIPE (iii).
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hepatocytes occur soon after seeding onto the substrate and
rarely progress beyond 2−3 days.
Galactose is a carbohydrate that is known to specifically bind
to hepatocytes to promote cell adhesion and function via the
ASGPR. We therefore wanted to assess if the pendent galactose
residues on our Gal-SDE-polyHIPE were accessible and selective
to primary rat hepatocytes as a means of improving cell adhesion
onto the scaffold. As glucose is not recognized by the ASGPR, it
was chosen as a selective control.
Cryopreserved primary rat hepatocytes were cultured in the
presence of serum proteins for up to 24 h and assessed for
albumin production, a typical marker for hepatic function
(Figure 8). We chose to culture in the presence of serum as this is
typical laboratory practice for hepatocyte culture, even though
this may increase nonselective cell binding onto the scaffold via
protein deposition.
After 3 h (cell adhesion period), hepatocytes produced a
significantly higher amount of albumin on Gal-SDE-polyHIPE
compared to that in Glu-SDE-polyHIPE and PFPA-SDE-
polyHIPE, suggesting that galactose is accessible and can
maintain selectivity with ASGPR. These data are consistent
with other 2D and 3D substrates functionalized with galactose
residues.42−44 However, as the culture period progressed, this
enhanced albumin synthesis was diminished, potentially due to
nonselective adherence onto the scaffold via serum protein
coating.
■ CONCLUSIONS
We have developed a polystyrene-based porous polymer using
polyHIPE technology that carries pendent-activated ester
functionality. The morphology of this material is comparable
to that of typical polystyrene-based polyHIPE scaffolds and
supports the 3D growth of hepatocyte-based cells. This material
can also undergo facile surface coupling reactions with
aminoethyl glycosides to render pendent carbohydrate function-
ality on the material surface. Preliminary studies with primary rat
hepatocytes on a galactose-functionalized polyHIPE show that
the carbohydrates are accessible and selective to cells entering the
scaffold, seen by an enhanced functional activity of the cells as
they initially adapt to the culture environment. This is the first
report of a surface-functional polystyrene-based polyHIPE for
3D hepatocyte applications. We therefore believe this material
could be a cornerstone for the development of tailored polyHIPE
scaffolds that promote the survival and differentiation of primary
hepatocytes used in drug discovery models.
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PFPA, pentafluorophenyl acrylate; HIPE, high internal phase
emulsion; polyHIPE, porous polymer fabricated from a high
internal phase emulsion; ASGPR, asialoglycoprotein receptor
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